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Abstract
Background: Although converging evidence has suggested that nicotinic acetylcholine receptors (nAChR) play a role in the
modulation of GABA release in rat hippocampus, the specific involvement of different nAChR subtypes at presynaptic level
is still a matter of debate. In the present work we investigated, using selective a7 and a4b2 nAChR agonists, the presence of
different nAChR subtypes on hippocampal GABA nerve endings to assess to what extent and through which mechanisms
they stimulate endogenous GABA release.
Methodology/Findings: All agonists elicited GABA overflow. Choline (Ch)-evoked GABA overflow was dependent to
external Ca
2+, but unaltered in the presence of Cd
2+, tetrodotoxin (TTX), dihydro-b-erythroidine (DHbE) and 1-(4,4-Diphenyl-
3-butenyl)-3-piperidinecarboxylic acid hydrochloride SKF 89976A. The effect of Ch was blocked by methyllycaconitine
(MLA), a-bungarotoxin (a-BTX), dantrolene, thapsigargin and xestospongin C, suggesting that GABA release might be
triggered by Ca
2+ entry into synaptosomes through the a7 nAChR channel with the involvement of calcium from
intracellular stores. Additionally, 5-Iodo-A-85380 dihydrochloride (5IA85380) elicited GABA overflow, which was Ca
2+
dependent, blocked by Cd
2+, and significantly inhibited by TTX and DHbE, but unaffected by MLA, SKF 89976A, thapsigargin
and xestospongin C and dantrolene. These findings confirm the involvement of a4b2 nAChR in 5IA85380-induced GABA
release that seems to occur following membrane depolarization and opening calcium channels.
Conclusions/Significance: Rat hippocampal synaptosomes possess both a7 and a4b2 nAChR subtypes, which can
modulate GABA release via two distinct mechanisms of action. The finding that GABA release evoked by the mixture of sub-
maximal concentration of 5IA85380 plus sub-threshold concentrations of Ch was significantly larger than that elicited by the
sum of the effects of the two agonists is compatible with the possibility that they coexist on the same nerve terminals.
These findings would provide the basis for possible selective pharmacological strategies to treat neuronal disorders that
involve the dysfunction of hippocampal cholinergic system.
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Introduction
It is well known that the activation of specific nicotinic
acetylcholine receptor (nAChR) subtypes enhances the release of
glutamate, noradrenaline, and acetylcholine from rodent hippo-
campal nerve endings [1,2]. nAChRs seem to play a role also in
the modulation of the release of GABA in the same brain area,
although the specific involvement of the different nAChR subtypes
may be more complex and is therefore still a matter of debate.
Studies using electrophysiological techniques have demonstrated
that functional a7 and a4b2 subtypes are present on terminals of
rat hippocampus and trigger the release of GABA [3–6]. The
presence of a7 nAChRs modulating GABA release has been
confirmed by several authors using different experimental
approaches [7–12]. On the contrary, some studies suggest that
the b2 subunit is the component of all the nAChRs that modulate
[
3H]GABA release in mouse brain synaptosomes [13,14], and
exclude the presence of a7 nAChR subtypes. In line with these
findings, Wonnacott et al. [15] reported that the nicotine-evoked
[
3H]GABA release from rat hippocampal synaptosomes was
blocked by dihydro-b-erythroidine (DHbE) but not by a-
bungarotoxin, suggesting that a7 nAChRs were not involved in
hippocampal GABA release. However, it has to be noted that a
particular a-bungarotoxin-insensitive a7 nAChR was found to
mediate enhancement of GABA release from chick central nervous
system [16], and that rat hippocampal a7 and b subunits can co-
assemble to form functional heteromeric receptors [17,18]. Finally,
there is evidence indicating that nAChRs are present on
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16911GABAergic neurons, at least on the preterminal level [19].
Moreover, the existence of a7 and non-a7 nAChRs on nerve
endings has also been challenged by the results of Kanno et al.
[20], who showed that both receptor subtypes exert some
modulatory effects on GABA release via a multi-synaptic control,
as they do not have a sufficient potency to modulate the release
under the control of a single synapse.
As for the functional diversity of nAChR subtypes, increasing
evidence support the possibility that different nAChR subtypes
trigger neurotransmitter release through different molecular
mechanisms [21–23].
Using purified hippocampal synaptosomes in superfusion, in the
present study we have a) investigated whether and to what extent
selective a7 and a4b2 receptor agonists [5,24–27] are able to
evoke endogenous GABA release and b) characterised the
molecular mechanisms involved in these effects. The results
indicate that, in rat hippocampus nAChRs of the a7 and a4b2
subtypes are present on nerve endings and stimulates the
endogenous GABA release via two distinct mechanisms of action.
Results
Figure 1A,B illustrates the time course of the endogenous
GABA release evoked by a 90 s pulse of choline (Ch) or 5-Iodo-A-
85380 dihydrochloride (5IA85380) reported to act selectively on
a7 and on a4b2 nAChR subtypes, respectively. The Ch- and the
5IA85380-evoked release of GABA showed a similar pattern
reaching a maximum corresponding to min 39.5 of superfusion
and decline to basal level at min 42.5 (Fig 1A,B). Since a certain
degree of desensitization may occur through the stimulation period
of 90 s it is possible that we are underestimating the stimulatory
effect of the two agonists on the GABA release.
Table 1 shows the effects of four different nicotinic agonists on
endogenous GABA release from rat purified hippocampal
synaptosomes in superfusion. In this study, we have used two a7
selective agonists Ch and PHA543613 hydrochloride
(PHA543613), and the a4b2 selective compounds 5IA85380 and
RJR2429 dihydrochloride (RJR2429). The GABA overflows
elicited by Ch (1 mM) and PHA543613 (100 mM) were respec-
tively 41.2562.76 and 32.5462.08 and closely resemble those
elicited by the two selective a4b2 receptor agonists 5IA85380
(10 nM) and RJR2429 (3 mM) (40.4363.71 and 32.3565.67
respectively). The stimulatory effects of these four agonists have
been compared to the GABA overflow evoked by depolarization
with 9 and 15 mM KCl. In the presence of 9 and 15 mM KCl in
the perfusion solution, the GABA overflows were 47.2265.98 and
109.1364.02, respectively. Therefore, the amount of endogenous
GABA released by all the four nicotinic agonists was quantitatively
very similar to that released by the lower concentration of KCl
(9 mM).
When synaptosomes were exposed to various concentrations of
Ch (0.01 mM–1 mM) or 5IA85380 (0.1 nM–1 mM), both
nicotinic agonists were found to increase GABA overflow in a
concentration-dependent manner, the apparent EC50 values for
Ch and 5IA85380 being 12.0660.66 mM (Hill coefficient: 1.5) and
to 2.5160.91 nM (Hill coefficient: 1.14), respectively (Fig. 2A,B).
In order to investigate on the presence of low affinity a4b2
nAChR subtypes we extended the concentration-response curve of
5IA85380 in presence and in absence of 2 mMD H bE. The result
show that 5IA85380 at higher concentrations (from 1 mMt o
1 mM) produced a stimulatory effect of endogenous GABA release
similar to that produced at 10 nM. This effect was completely
blocked in presence of 2 mMD H bE (Fig. 2B).
The Ch (1 mM)-evoked release was significantly antagonised by
methyllycaconitine (MLA; 10 nM), a-bungarotoxin (a-BTX,
100 nM) and unaffected by DHbE( 1 mM) confirming the
involvement of an a7 nAChR. The voltage operated Na
+ blocker
tetrodotoxin (TTX) (1 mM) and SKF 89976A (10 mM), a specific
inhibitor of the GABA carrier, did not modify the Ch (1 mM)-
evoked GABA overflow (Fig. 3A). The ability of Ch (1 mM) to
evoke GABA overflow was totally external Ca
2+-dependent but
was insensitive to the non specific voltage-operated Ca
2+ channel
(VOCC) blocker Cd
2+ (50 mM), suggesting that Ca
2+ entry into
synaptosomes following Ch exposure might occur through the a7
Figure 1. Time course of GABA release in response to different
agonists. Stimulatory effects of Ch (1 mM; .) (A) and 5IA85380
(10 nM; ¤) (B). Values are from two experiments and represent mean 6
SEM of eight replicate superfusion chambers per condition (basal or
evoked release). **p,0.01, ***p,0.001 versus time 36.5;
#p,0.05,
##p,0.01 versus basal release (N). Two way ANOVA followed by Tukey-
Kramer post hoc test.
doi:10.1371/journal.pone.0016911.g001
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abolished by dantrolene (10 mM), thapsigargin (10 mM) and
xestospongin C (1 mM) a finding consistent with a fundamental
role of intracellular calcium stores in mediating the a7 response
(Fig. 3B). The natural neurotransmitter ACh (100 mM), tested in
presence of atropine (0.1 mM) to avoid muscarinic effects,
produced an increase of the GABA release quantitatively similar
to the sum of the effects produced by Ch and 5IA85380 and its
stimulatory effect was partially inhibited (260%) by CdCl2
(50 mM).
The 5IA85380 (10 nM)-evoked GABA overflow was blocked by
DHbE( 1 mM) (279%) and unaffected by MLA (10 nM),
confirming the involvement of an a4b2 nAChR subtype. The
effect of 5IA85380 (10 nM) was significantly inhibited (274%) in
presence of TTX (1 mM) but unaffected by the specific inhibitor of
the GABA carrier SKF 89976A (10 mM) (Fig. 4A). The effect of
5IA85380 (10 nM) was almost totally Ca
2+ dependent, blocked by
Cd
2+ (50 mM) while no significant attenuation of the stimulatory
effect of 5IA85380 (10 nM) was found in presence of dantrolene
(10 mM), thapsigargin (10 mM) and xestospongin C (1 mM), thus
excluding a significant involvement of calcium release from
intracellular calcium stores following activation of the a4b2
nAChR (Fig. 4B). DHbE( 1mM), MLA (10 nM), TTX (1 mM),
CdCl2 (50 mM) and dantrolene (10 mM) thapsigargin (10 mM) and
xestospongin C (1 mM) did not produce any significant effect on
basal GABA release on their own.
The simultaneous presence of 5IA85380 (3 nM) in the
superfusion fluid, with two subthreshold concentrations of Ch
(1 mM and 10 mM), provoked a synergistic GABA overflow that
was significantly larger than that elicited by the sum of the effects
of the two agonists alone (Fig. 5). The co-administration of
maximal concentration of 5IA85380 (10 nM) and Ch (1 mM)
produced only an additive effect. The presence of Ch (30 mM) plus
two subthreshold concentration of 5IA85380 (1 nM and 0.1 nM)
did not show any synergistic or antagonistic effects (Fig. 5).
Finally, as illustrated in Fig. 6, both 5IA85380 (10 nM) and Ch
(1 mM) increased significantly the apparent [Ca
2+]i in synapto-
somes. The increase produced by the two agonists was similar
compared to that produced by 15 mM KCl.
Discussion
In the present work, we investigated the effect of nAChR
activation on the release of endogenous GABA from rat purified
isolated hippocampal synaptosomes. We have shown that selective
a4b2 and a7 receptor agonists produced enhancement of
endogenous GABA release through two distinct intracellular
mechanisms.
Our results obtained with the specific a7 agonist Ch show that
this drug was able to elicit endogenous GABA release from
purified hippocampal synaptosomes at concentrations (EC50
=12.0660.66 mM) quite different from those (EC50 =1.6 mM)
necessary to activate the a7 nAChRs in cultured hippocampal
neurons [4,5]. This stimulatory effect was antagonised by MLA, a-
BTX and not by DHbE indicating that, although obtained at very
low concentration, the release seems to be mediated by a a7
nAChR subtype. This Ch-mediated GABA release was not
inhibited in the presence of TTX, therefore excluding a major
involvement of the voltage dependent sodium channels. On the
other hand, the TTX-insensitive carrier-independent enhance-
ment of GABA release by Ch was both dependent on external
calcium and prevented by thapsigargin, xestospongin C and
dantrolene. Therefore, the following possible sequence of events
underlying the TTX-insensitive, choline-induced GABA release
can be suggested. First Ch, even at very low concentration, can
increase Ca
2+ influx directly through the a7 nAChR channel,
which is known to exhibit a high permeability for Ca
2+ [7,28]. The
influx of this cation may initiate a Ca
2+-induced Ca
2+ release from
the endoplasmic reticulum stores that, finally, generates the
increase of GABA release. The data showing the effects of Ch
on cytoplasmic Ca
2+ concentration (Fig. 6) support this sequence
of events. Moreover in line with our results, it has been reported
that, in the absence of incoming potentials, Ca
2+ influx into
hippocampal mossy fibers through a7 nAChRs triggers Ca
2+-
induced Ca
2+ release from presynaptic stores, which induces a
marked increase of glutamate release leading to high frequency
bursts of mEPSCs in CA3 pyramidal neurons [29].
However, since a7 nAChRs are also permeable to Na
+, it might
be argued that their influx through the receptor channel could
cause a TTX-insensitive depolarization followed by VOCC
opening, entry of extracellular calcium, subsequent Ca
2+-induced
Ca
2+ release from intracellular stores, and stimulation of GABA
release. Such chain of reactions, however, seems unlikely to occur,
as the broad spectrum blocker of VOCCs Cd
2+ was not able to
affect the Ch-induced release of GABA.
Similar results were recently obtained in pre-fontal cortex
synaptosomes and hippocampal mossy fiber terminals, where
activation of a7 nAChRs by nicotine has been shown to enhance
glutamate release in an extracellular Ca
2+-dependent and
VOCCs-independent manner and without causing membrane
Table 1. Effects of selective nAChR subtype agonists on endogenous GABA overflow from rat hippocampal synaptosomes.
Drugs Endogenous GABA overflow (pmol/mg prot)
a7 nAChR subtype agonists
Ch (1 mM) 41.2562.76
PHA543613 (100 mM) 32.5462.08
a4b2 nAChR subtype agonists
5IA85380 (10 nM) 40.4363.71
RJR2429 (3 mM) 32.3565.67
KCl (9 mM) 47.22612.98
KCl (15 mM) 109.1364.02
##
Data are means 6 SEM of three experiments run in triplicate. For experimental details see Materials and Methods.
##p,0.01 versus KCl (9 mM).
One way ANOVA followed by Tukey-Kramer post hoc test.
doi:10.1371/journal.pone.0016911.t001
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Ca
2+-induced Ca
2+ release seems to represent the key mechanism
capable of inducing glutamate exocytosis.
As far as the low concentrations of Ch able to elicit GABA
release, it should be noted that this agonist elicits different nicotinic
responses according to the concentration used [5]. Indeed, at
concentrations between 50–300 mM, Ch was found to cause mild
activation of a7 nAChRs and an increase of Ca
2+ influx in neurons
able to induce a cascade of intracellular metabotropic functions;
however, at these low concentrations, the activation of a7 nAChRs
was not sufficient to induce excitation of hippocampal interneu-
rons [6]. Our observation that the a7 nAChRs are sensitive to low
concentration of Ch could be explained by the fact that access of
Ch to receptors is of course easier in synaptosomes than in slices.
Indeed, it has been shown, in electrophysiological experiments on
hippocampal GABAergic interneurons that Ch induces action
potentials by activating putative a7 nAChRs either at high (mM)
concentration after short (tens of millis) exposure or at low (mM)
concentration with long (10–20 sec) exposure [5]. It is therefore
likely that the apparent EC50 of Ch or for a7 nAChRs is lower in
synaptosomes than in electrophysiological preparations in view of
the longer exposure time and higher efficacy of the agonist in the
former preparation. However the possibility that at least in part
some of these receptors, which are not completely blocked by a-
BTX (Fig. 3), are different from the typical a7 nAChRs [5,16] has
to be also taken in consideration.
Beside a7 nAChRs, our results demonstrate that hippocampal
GABAergic nerve terminals also possess functional a4b2 nAChRs.
In fact, in our experiments, the selective a4b2 receptor agonist
5IA85380 was able to elicit endogenous GABA release from
purified hippocampal synaptosomes with an EC50 in the range of
the high affinity for nAChRs as previously reported [30]. It is
interesting to note that a low affinity nAChRs, DHbE insensitive,
which modulate rubidium efflux have been demonstrated to be
present in rat hippocampus [30]. As reported these receptors
represent a new and previously undescribed nAChRs which may
be of significant [30].
Our results using high concentrations of 5IA85380 show that
the stimulatory effects on GABA release of this compound was
similar to that produced by lower concentrations (10 nM) and was
always inhibited in presence of 2 mMD H bE. In our experimental
conditions it seems therefore unlikely that the DHbE insensitive,
a4b2 nAChRs are significantly involved in the stimulation of
endogenous GABA release from hippocampal isolated nerve
endings. However, the possibility that these receptors, previously
demonstrated monitoring Rubidium efflux from rat hippocampal
synaptosomes, could be present on other selective neuronal
population has to be also considered.
As for the molecular mechanisms, the 5IA85380-evoked,
carrier-independent endogenous GABA release was external
Ca
2+-dependent and completely blocked by Cd
2+, while dantro-
lene, thapsigargin and xestospongin C were devoid of any effect,
indicating that opening of VOCCs, but not Ca
2+ release from
intracellular stores, is an obligatory step in the a4b2-evoked
facilitation of GABA release.
Interestingly, the 5IA85380-evoked GABA overflow was
abolished in the presence of TTX, demonstrating that opening
of voltage dependent sodium channels is required for the a4b2
nAChR effect to occur. At a first glance, this result seems at odds
with the general notion that presynaptic receptor-mediated effects
are TTX-insensitive and since TTX has not been shown to be
active at any nAChR subtype tested [31]. However, this view has
been challenged by different studies showing that presynaptic
nAChR effects are external sodium-dependent and can be largely
prevented by the selective voltage dependent sodium channel toxin
[32–34]. Therefore, it is generally accepted that neurotransmitter
release evoked by the activation of non-a7 nAChRs is a Na
+- and
Ca
2+-dependent process and is mediated by N- and/or P/Q-type
of VOCCs [22,35,36] with a lack of L-type VOCCs involvement
[22].
The present study, therefore, demonstrates that, in the rat
hippocampus, two nAChR subtypes are present on GABAergic
Figure 2. Concentration-dependent effect of Ch and 5IA85380
on endogenous GABA overflow from rat hippocampal synap-
tosomes. (A) Data are mean 6 SEM of 3–6 experiments for each
concentration run in triplicate. **p,0.01, ***p,0.001 versus Ch
(100 nM);
#p,0.05,
###p,0.001, versus Ch (1 mM);
$$p,0.01,
$$$p,0.001 versus Ch (10 mM). One way ANOVA followed by Tukey-
Kramer post hoc test (Ch =m). (B) Data are mean 6 SEM of 3–6
experiments for each concentration run in triplicate (three superfusion
chambers for each experimental condition). ***p,0.001 versus
5IA85380 (10 pM);
#p,0.05,
##p,0.01
###p,0.001 versus 5IA85380
(100 pM);
$p,0.05,
$$p,0.01,
$$$p,0.001 versus 5IA85380 (1 nM);
up,0.05, uup,0.01 versus 5IA85380 (3 nM);
1 p,0.05,
111 p,0.001
versus 5IA85380 alone respectively. One way ANOVA followed by
Tukey-Kramer post hoc test (5IA85380 = N; 5IA85380 + DHbE2mM=
#)
doi:10.1371/journal.pone.0016911.g002
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GABA release via two distinct mechanisms. While the physiolog-
ical significance of two different nAChRs both modulating
hippocampal basal release of GABA could be difficult to explain
their role in the mechanism of action of nicotine could be relevant.
The hippocampus contains many sources of GABA nerve
terminals, including those derived both from GABAergic inter-
neurons and from septo-hippocampal GABAergic afferents.
Previous results have demonstrated that 65% of GABA hippo-
campal interneurons express a7 receptors while only 35% express
the a4b2 subtypes [3] and that nAChR activation excites distinct
subtypes of hippocampal interneurons [37,38].
Nevertheless, the possibility that at least a certain amount of
synaptosomes (although a minority), derived from the septo-
hippocampal GABAergic projections, possesses nAChR subtypes
can not be ruled out. Indeed, nAChRs have been found in a
proportion of GABAergic cells innervating hippocampal inter-
neurons and recent data of in situ hybridization study showed the
presence of a7 and b2 nAChR subunit mRNAs in most
GABAergic neurons in the medial septum [39–41]. Although
Figure 3. Characterization of Ch-evoked endogenous GABA release. (A) Effect of MLA, (a-BTX, DHbE, TTX and SKF 89976A on endogenous
GABA overflow evoked by Ch from rat hippocampal synaptosomes. Synaptosomes were depolarised with Ch for 90 s at t=38 min of superfusion.
When appropriate antagonists were introduced 8 min before depolarization. Data are mean 6 SEM of 3–6 experiments run in triplicate. ***p,0.001,
**p,0.01 versus Ch-evoked GABA overflow. One way ANOVA followed by Dunnett post hoc test. (B) Effect of Ca
2+ free, Cd
2+, thapsigargin,
dantrolene, and xestospongin C on endogenous GABA overflow evoked by Ch (1 mM) or by ACh plus atropine from rat hippocampal synaptosomes.
When appropriate, Ca
2+ was omitted 18 min before Ch. Data are mean 6 SEM of 3–6 experiments run in triplicate. **p,0.01, ***p,0.001 versus Ch-
evoked GABA overflow,
###p,0.001 versus ACh evoked GABA overflow. One way ANOVA followed by Dunnett post hoc test.
doi:10.1371/journal.pone.0016911.g003
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dendrites membrane components of the medial septal neurons, the
possibility that they are present also on the nerve endings is very
likely. A recent approach using in situ hybridization corroborates
our neurochemical findings, in particular confirms the presence of
specific receptor subtypes on GABAergic neurons [42].
In order to demonstrate the possible co-expression and co-
operation of a4b2 and a7 nAChR subtypes on the same nerve
endings we have performed some experiments varying the
concentrations of the two agonists together using subthreshold
concentration of one agonist in presence of submaximal
concentration of the other and viceversa. Our results show that
the a4b2 nAChRs may exert a permissive role on the activation of
Ch mediated GABA release (Fig. 5) suggesting that, at least in part,
the a4b2 and a7 nAChRs may coexist on the same nerve endings.
This synergistic effect did not occur when GABA release was
stimulated by submaximal concentration of Ch in presence of
subthreshold concentrations of 5IA85380. This finding favor the
idea that the TTX-sensitive depolarization of the nerve endings
elicited by the activation of the a4b2 nAChRs may play an
important role in the synergistic interaction as previously reported
[43,44] for a review see also [45].
Figure 4. Characterization of 5IA85380 endogenous GABA release. (A) Effect of DHbE, MLA, TTX and SKF 89976A on endogenous GABA
overflow evoked by 5IA85380 from rat hippocampal synaptosomes. Synaptosomes were depolarised with 5IA85380 for 90 s at t=38 min of
superfusion. When appropriate, antagonists were introduced 8 min before depolarization. Data are mean 6 SEM of 3–6 experiments run in triplicate.
***p,0.001 versus 5IA85380 evoked GABA overflow. One way ANOVA followed by Dunnett post hoc test. (B) Effect of Ca
2+ free, Cd
2+ and
thapsigargin, dantrolene, and xestospongin C on endogenous GABA overflow evoked by 5IA85380 from rat hippocampal synaptosomes. When
appropriate, antagonists were introduced 8 min before 5IA85380. Data are mean 6 SEM of 3–6 experiments run in triplicate. ***p,0.001 versus
5IA85380 evoked GABA overflow. One way ANOVA followed by Dunnett post hoc test.
doi:10.1371/journal.pone.0016911.g004
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endings and elicit GABA release, it can be also hypothesised that
they are differently located on the membranes of the nerve
terminals and subserve different presynaptic functional roles. The
fact that a7 nAChRs respond to low concentrations of Ch open up
the possibility that they might be activated by volume transmission
in a non synaptic manner by the diffusing Ch, which derives from
acetylcholine hydrolysis [46,47].
The understanding of the physiological role of these nAChRs
and the definition of their location would provide the basis for
possible selective pharmacological strategies to treat neuronal
disorders, which involve the disruption of the normal function of
the hippocampal cholinergic system.
Materials and Methods
Animals and brain tissue preparation
Adult male Sprague–Dawley rats (200–250 g) were housed at
constant temperature (22 6 1uC) and relative humidity (50%)
under a regular light–dark schedule (light 7 a.m.–7 p.m.). Food
and water were freely available. The animals were killed by
decapitation and the hippocampus rapidly removed at 0–4uC. The
experimental procedures were approved by the Ethical Committee
of the Pharmacology and Toxicology Section, Department of
Experimental Medicine, in accordance with the European
legislation (European Communities Council Directive of 24
November 1986, 86/609/EEC) and were approved by Italian
legislation on animal experimentation (Decreto Ministeriale
number 124/2003-A). All efforts were made to minimize animal
suffering and to use the minimal number of animals necessary to
produce reliable results.
Experiments of release
Purified synaptosomes were prepared on PercollH gradients
(Sigma-Aldrich, St Louis, MO, USA) essentially according to
Nakamura et al. [48], with only minor modifications. Briefly, the
tissue was homogenised in 6 volumes of 0.32 M sucrose, buffered
at pH 7.4 with Tris–HCl, using a glass-teflon tissue grinder
(clearance 0.25 mm, 12 up–down strokes in about 1 min). The
homogenate was centrifuged (5 min, 1000 g at 4uC) to remove
nuclei and debris; the supernatant was gently stratified on a
discontinuous PercollH gradient (2%, 6%, 10%, and 20% v/v in
Tris-buffered sucrose) and centrifuged at 33500 g for 5 min at
4uC. The layer between 10% and 20% PercollH (synaptosomal
fraction) was collected, washed by centrifugation and resuspended
in physiological HEPES-buffered medium having the following
composition (mM): NaCl 128, KCl 2.4, CaCl2 3.2, KH2PO4 1.2,
MgSO4 1.2, HEPES 25, pH 7.5, glucose 10, pH 7.2–7.4 [13].
Synaptosomal protein content following purification was 10–15%
of that in the supernatant stratified on the PercollH gradient.
The synaptosomal suspension was layered on microporous
filters at the bottom of a set of parallel superfusion chambers
maintained at 37uC ([49]; Superfusion System, Ugo Basile,
Comerio, Varese, Italy). Synaptosomes were superfused at 1 ml/
min with standard physiological medium as previously described.
The system was first equilibrated during 36.5 min of superfusion;
subsequently, four consecutive 90 s fractions of superfusate were
collected. Synaptosomes were exposed to agonists for 90 s starting
Figure 5. Effect of the simultaneous presence of 5IA85380 and Ch in the superfusion fluid on endogenous GABA overflow from rat
hippocampal synaptosomes. Synaptosomes were stimulated simultaneously with 5IA85380 plus Ch at different concentrations for 90 s at
t=38 min of superfusion. Data are mean 6 SEM of 4–6 experiments run in triplicate. In order to evaluate whether the effect of the co-administration
of the two agonists was significantly different compared to the sum of the two agonists alone, we have added, in each experiment, to the stimulatory
effect of 5IA85380 (3 nM) the average effect of subthreshold concentration of Ch alone (gray column) and, similarly to the effect of Ch (30 mM) the
effect of submaximal concentrations of 5IA85380. ***p,0.001 versus their respective controls (the sum of 5IA85380 plus Ch). We have also tested the
stimulatory effect of 5IA85380 plus Ch (black bar) at their maximal concentration. Two-tailed Student’s t-test.
doi:10.1371/journal.pone.0016911.g005
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being added 8 min before agonists. The evoked overflow was
calculated by subtracting the corresponding basal release from
each fraction and was expressed as pmol/mg of synaptosomal
proteins. We have previously amply demonstrated that in our
superfusion system the possible effects of drugs operated indirectly
by other mediators in the monolayer of synaptosomes in
superfusion are absolutely minimised [46].
Endogenous GABA determination
Endogenous GABA was measured by high performance
liquid chromatography analysis following precolumn derivati-
zation with o-phthalaldehyde and resolution through a C18-
reverse phase chromatographic column (1064.6 mm, 3 mm;
Chrompack, Middleburg, The Netherlands) coupled with
fluorometric detection( e x c i t a t i o nw a v e l e n g t h3 5 0n m ;e m i s s i o n
wavelength 450 nm). Homoserine was used as internal standard.
Buffers and gradient program were prepared and executed as
follows: solvent A, 0.1 M sodium acetate (pH 5.8)/methanol,
80:20; solvent B, 0.1 M sodium acetate (pH 5.8)/methanol,
20:80; solvent C, sodium acetate (pH 6.0)/methanol, 80:20;
gradient program, 100% C for 4 min from the initiation of the
program; 90% A and 10% B in 1 min; 42% A and 58% B in
14 min; 100% B in 1 min; isocratic flow 2 min; 100% C in
3 min; flow rate 0.9 ml/min.
Monitoring cytoplasmic Ca
2+ concentration
Cytoplasmic Ca
2+ concentration ([Ca
2+]i) was monitored in
purified synaptosomes using the fluorescent dye FURA PE 3-AM
[50]. Synaptosomes were incubated for 40 min at 37uC in the
dark, while gently shaking, in a medium containing 20 mM of
CaCl2 and 5 mM FURA PE 3-AM (and 1% DMSO). Control
synaptosomes containing 1% DMSO, but no FURA PE 3-AM,
were prepared to measure auto-fluorescence. Synaptosomal
suspension was washed to remove extra-particle FURA PE 3-
AM. Pellets were resuspended in ice-cold medium, divided into
200 ml aliquots (each containing 200 mg protein) and stored on ice
until use. Measures were obtained within 2 h. To estimate the
apparent ([Ca
2+]i), a 200 ml aliquot of synaptosomes was diluted
into 1.8 ml of physiological medium, containing 3.2 mM CaCl2,
and incubated at 37uC for 5 min. Fluorescence was recorded for at
least 1 min before addition of 15 mM KCl or 10 nM 5IA85380 or
1 mM Ch. Measurements were made at 37uC in a thermostated
cuvette under continuous stirring using a RF-5301PC dual
wavelength spectrofluorometer (Shimadzu, Japan) and by alter-
nating the excitation wavelength of 340 and 380 nm. Fluorescent
emission was monitored at 510 nm. Calibration of the fluorescent
signals was performed at the end of each experiments by adding
10 mM ionomycin in the presence of 3.2 mM Ca
2+, to obtain
Fmax, followed by 10 mM EGTA (adjusted to pH 8 with 3 mM
Tris), to obtain Fmin [50]. Intrasynaptosomal FURA PE 3-AM
was determined for each synaptosomal preparation by adding
40 mM Mn
2+ to quench the extracellular fluorescence; this
Mn
2+-quenched fluorescence comprised 7–10% of the total
fluorescence at two wavelengths and was stable for the duration
of the experiments. After correcting for the extracellular dye,
[Ca
2+]i was calculated by the equation of Grynkiewicz et al. [50],
using a KD of 250 nM for the Ca
2+/FURA PE 3-AM complex.
Statistical analysis
Multiple comparisons were performed with one-or two way
ANOVA followed by an appropriate post hoc test (Dunnett and
Tukey-Kramer). Direct comparison between two groups were
performed with two-tailed Student’s t-test. Data were considered
significant for p,0.05, at least. The EC50 and Hillslope have been
calculated according to a four parameter logistic curve equation
[y= min+max–min/1+(x/EC50)
Hillslope] of Sigma Plot 8.0 (Jandel
Scientific, San Rafael, CA, USA).
Chemicals
PercollH, Choline Iodide, CdCl2, dantrolene, dimethyl sulfoxide,
FURA PE 3-AM and a-bungarotoxin (Sigma-Aldrich, St Louis,
MO, USA); 5-Iodo-A-85380, RJR2429 dihydrochloride,
PHA543613 hydrochloride, dihydro-b-erythroidine hydrobromide,
methyllycaconitine citrate, thapsigargin and SKF 89976A hydro-
chloride (Tocris Bioscience, Bristol, UK); TTX (Ascent Scientific,
Princeton, NJ, USA); xestospongin C (Inalco, Milan, Italy).
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Figure 6. Effect of 15 mM KCl, Ch and 5IA85380 on the
cytosolic Ca
2+ concentration [Ca
2+]i induced in rat hippocam-
pal synaptosomes. Synaptosomes were loaded with FURA PE-3 AM,
resuspended in standard HEPES-buffered medium and incubated for
40 min before fluorometric measurements. Basal Ca
2+ levels were
measured for 2 min before addition of Ch, 5IA85380 or KCl. Data are
expressed as means 6 SEM of three experiments run in duplicate. **
p,0.01, *** p,0.001 vs. basal [Ca
2+]i in synaptosomes (One way
ANOVA followed by Dunnett Multiple Comparison Test).
doi:10.1371/journal.pone.0016911.g006
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